Caldwell Sutter Capital’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Sell
5,195
-182
-3% -$12.7K 0.14% 155
2026
Q1
$345K Buy
5,377
+185
+4% +$12.2K 0.14% 153
2025
Q4
$324K Buy
5,192
+50
+1% +$3.06K 0.14% 155
2025
Q3
$308K Sell
5,142
-5
-0.1% -$291 0.13% 158
2025
Q2
$293K Sell
5,147
-343
-6% -$18.4K 0.13% 153
2025
Q1
$279K Buy
5,490
+69
+1% +$3.49K 0.13% 159
2024
Q4
$259K Buy
5,421
+230
+4% +$11.6K 0.12% 167
2024
Q3
$274K Buy
5,191
+222
+4% +$11.3K 0.13% 163
2024
Q2
$246K Buy
4,969
+186
+4% +$9.26K 0.12% 172
2024
Q1
$240K Buy
4,783
+376
+9% +$18.2K 0.12% 172
2023
Q4
$211K Buy
4,407
+398
+10% +$17.8K 0.11% 184
2023
Q3
$175K Buy
4,009
+320
+9% +$14.6K 0.1% 188
2023
Q2
$170K Buy
3,689
+3,083
+509% +$142K 0.09% 196
2023
Q1
$27.4K Buy
606
+125
+26% +$5.57K 0.02% 308
2022
Q4
$20.2K Buy
+481
New +$19.5K 0.02% 222

Other funds holding VEA

Caldwell Sutter Capital's VEA Position: Q2 2026 in Review

Caldwell Sutter Capital reduced its Vanguard FTSE Developed Markets ETF (VEA) stake by 3.4% in Q2 2026, selling an estimated $12.7K and leaving 5,195 shares worth $370K. The position accounts for 0.14% of the portfolio, ranked #155.

Caldwell Sutter Capital first reported a position in VEA in Q4 2022 and has held it in 15 quarters since. 3,007 funds tracked by Wall St. Rank hold VEA as of Q2 2026.

  • Caldwell Sutter Capital held 5,195 shares of Vanguard FTSE Developed Markets ETF worth $370K as of Q2 2026.
  • Caldwell Sutter Capital sold 182 Vanguard FTSE Developed Markets ETF shares in Q2 2026, an estimated $12.7K.
  • Vanguard FTSE Developed Markets ETF made up 0.14% of Caldwell Sutter Capital's portfolio in Q2 2026, its #155 holding.
  • Caldwell Sutter Capital first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2022 and has held it in 15 quarters since.
  • 3,007 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.